These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Essential fatty acid treatment--effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats. Tomlinson DR, Robinson JP, Compton AM, Keen P. Diabetologia; 1989 Sep; 32(9):655-9. PubMed ID: 2477293 [Abstract] [Full Text] [Related]
8. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil. Tomlinson DR, Moriarty RJ, Mayer JH. Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576 [Abstract] [Full Text] [Related]
9. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats. Mizuno K, Kato N, Matsubara A, Nakano K, Kurono M. Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819 [Abstract] [Full Text] [Related]
10. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy. Shindo H, Tawata M, Aida K, Onaya T. J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506 [Abstract] [Full Text] [Related]
11. Reversal of deficits in axonal transport and nerve conduction velocity by treatment of streptozotocin-diabetic rats with myo-inositol. Tomlinson DR, Mayer JH. Exp Neurol; 1985 Aug; 89(2):420-7. PubMed ID: 2410289 [Abstract] [Full Text] [Related]
12. Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve. Coppey LJ, Davidson EP, Dunlap JA, Lund DD, Yorek MA. Int J Exp Diabetes Res; 2000 Aug; 1(2):131-43. PubMed ID: 11469397 [Abstract] [Full Text] [Related]
13. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats. Cameron NE, Cotter MA, Robertson S. Q J Exp Physiol; 1989 Nov; 74(6):917-26. PubMed ID: 2512591 [Abstract] [Full Text] [Related]
14. Reduced motor nerve conduction velocity and Na(+)-K(+)-ATPase activity in rats maintained on L-fucose diet. Reversal by myo-inositol supplementation. Yorek MA, Wiese TJ, Davidson EP, Dunlap JA, Stefani MR, Conner CE, Lattimer SA, Kamijo M, Greene DA, Sima AA. Diabetes; 1993 Oct; 42(10):1401-6. PubMed ID: 8397126 [Abstract] [Full Text] [Related]
20. Effects of novel aldose reductase inhibitors, M16209 and M16287, on streptozotocin-induced diabetic neuropathy in rats. Kato K, Nakayama K, Ohta M, Murakami N, Murakami K, Mizota M, Miwa I, Okuda J. Eur J Pharmacol; 1991 Feb 07; 193(2):185-91. PubMed ID: 1828768 [Abstract] [Full Text] [Related] Page: [Next] [New Search]